The p53 isoforms are differentially modified by Mdm2

被引:32
作者
Camus, Suzanne [2 ]
Menendez, Sergio [2 ]
Fernandes, Kenneth [1 ]
Kua, Nelly [2 ]
Liu, Geng [3 ]
Xirodimas, Dimitris P. [3 ]
Lane, David P. [2 ]
Bourdon, Jean-Christophe [1 ]
机构
[1] Univ Dundee, Coll Med, Ctr Oncol & Mol Med, Dundee, Scotland
[2] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore
[3] Ctr Rech Biochim Macromol, UMR 5237, Montpellier, France
关键词
p53; isoform; Mdm2; degradation; ubiquitination; neddylation; nedd8; splice; nutlin; INFLUENCES SIRNA EFFICACY; P53-RELATED PROTEIN P73; TUMOR-SUPPRESSOR P53; C-TERMINUS; IN-VIVO; TRANSCRIPTIONAL ACTIVITY; FUNCTIONAL-ANALYSIS; STABILITY CONTROL; ONCOPROTEIN MDM2; DNA-DAMAGE;
D O I
10.4161/cc.20119
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The discovery that the single p53 gene encodes several different p53 protein isoforms has initiated a flurry of research into the function and regulation of these novel p53 proteins. Full-length p53 protein level is primarily regulated by the E3-ligase Mdm2, which promotes p53 ubiquitination and degradation. Here, we report that all of the novel p53 isoforms are ubiquitinated and degraded to varying degrees in an Mdm2-dependent and -independent manner, and that high-risk human papillomavirus can degrade some but not all of the novel isoforms, demonstrating that full-length p53 and the p53 isoforms are differentially regulated. In addition, we provide the first evidence that Mdm2 promotes the NEDDylation of p53 beta. Altogether, our data indicates that Mdm2 can distinguish between the p53 isoforms and modify them differently.
引用
收藏
页码:1646 / 1655
页数:10
相关论文
共 54 条
[1]   p53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damage [J].
Aoubala, M. ;
Murray-Zmijewski, F. ;
Khoury, M. P. ;
Fernandes, K. ;
Perrier, S. ;
Bernard, H. ;
Prats, A-C ;
Lane, D. P. ;
Bourdon, J-C .
CELL DEATH AND DIFFERENTIATION, 2011, 18 (02) :248-258
[2]   IMMUNOLOGICALLY DISTINCT P53 MOLECULES GENERATED BY ALTERNATIVE SPLICING [J].
ARAI, N ;
NOMURA, D ;
YOKOTA, K ;
WOLF, D ;
BRILL, E ;
SHOHAT, O ;
ROTTER, V .
MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (09) :3232-3239
[3]   Mdm2 binds p73α without targeting degradation [J].
Bálint, E ;
Bates, S ;
Vousden, KH .
ONCOGENE, 1999, 18 (27) :3923-3929
[4]   p53 isoforms can regulate p53 transcriptional activity [J].
Bourdon, JC ;
Fernandes, K ;
Murray-Zmijewski, F ;
Liu, G ;
Diot, A ;
Xirodimas, DP ;
Saville, MK ;
Lane, DP .
GENES & DEVELOPMENT, 2005, 19 (18) :2122-2137
[5]   p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients [J].
Bourdon, Jean-Christophe ;
Khoury, Marie P. ;
Diot, Alexandra ;
Baker, Lee ;
Fernandes, Kenneth ;
Aoubala, Mustapha ;
Quinlan, Philip ;
Purdie, Colin A. ;
Jordan, Lee B. ;
Prats, Anne-Catherine ;
Lane, David P. ;
Thompson, Alastair M. .
BREAST CANCER RESEARCH, 2011, 13 (01)
[6]   Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6 [J].
Camus, S. ;
Menendez, S. ;
Cheok, C. F. ;
Stevenson, L. F. ;
Lain, S. ;
Lane, D. P. .
ONCOGENE, 2007, 26 (28) :4059-4070
[7]   Differences in the ubiquitination of p53 by Mdm2 and the HPV protein E6 [J].
Camus, S ;
Higgins, M ;
Lane, DP ;
Lain, S .
FEBS LETTERS, 2003, 536 (1-3) :220-224
[8]   MAPPING OF THE P53 AND MDM-2 INTERACTION DOMAINS [J].
CHEN, JD ;
MARECHAL, V ;
LEVINE, AJ .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (07) :4107-4114
[9]   p53 isoform Δ113p53 is a p53 target gene that antagonizes p53 apoptotic activity via BclxL activation in zebrafish [J].
Chen, Jun ;
Ng, Sok Meng ;
Chang, Changqing ;
Zhang, Zhenhai ;
Bourdon, Jean-Christophe ;
Lane, David P. ;
Peng, Jinrong .
GENES & DEVELOPMENT, 2009, 23 (03) :278-290
[10]   ΔN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53 [J].
Courtois, S ;
Verhaegh, G ;
North, S ;
Luciani, MG ;
Lassus, P ;
Hibner, U ;
Oren, M ;
Hainaut, P .
ONCOGENE, 2002, 21 (44) :6722-6728